Skip to main content
Log in

The expression of interleukin-23 (p19/p40) and inteleukin-12 (p35/p40) in psoriasis skin

  • Published:
Journal of Huazhong University of Science and Technology Aims and scope Submit manuscript

Summary

In order to investigate the mRNA expression and function of interleukin-23 (p19/p40) and interleukin-12 (p35/p40) in the psoriatic lesion, no-lesion and normal human skin, reverse transcriptase-polymerase chain reaction (RT-PCR) was used to detect the expression of IL-23 (p19/p40) and IL-12 (p35/p40). The results showed that the expression of IL-23p19 mRNA and p40 (IL-12/IL-23) mRNA were higher in psoriatic lesion than those of non-lesional skin and normal skin. The levels of IL-23p19 mRNA and p40 (IL-12/IL-23) mRNA were higher in psoriatic non-lesional skin than normal skin. However, no significant difference was found in the level of IL-12p35 mRNA among the psoriatic lesional skin, non-lesional skin and normal skin. It was suggested that IL-23 might be more important in the pathogenesis of psoriasis than IL-12.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brombacher F, Kastelein R A, Alber G. Novel IL-12 family members shed light on the orchestration of Th1 responses. TRENDS, 2003,24(4):207

    CAS  Google Scholar 

  2. Iwakura Y, Ishiqame H. The IL-23/IL-17 axis in inflammation. J Clin Invest, 2006,116(5):1218

    Article  PubMed  CAS  Google Scholar 

  3. Cua DJ, Sherlock J, Chen Y et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature, 2003, 421:744

    Article  PubMed  CAS  Google Scholar 

  4. Yano S, Komine M, Fujimoto M et al. Interleukin 15 induces the signals of epidermal proliferation through ERK and PI3-kinase in a human epidermal keratinocyte cell line, HaCaT. Biochem Biophys Res Commun, 2003,301(4):841

    Article  PubMed  CAS  Google Scholar 

  5. Kopp T, Lenz P, Bello-Fernandez C et al. IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity. J Immunol, 2003,170(11):5438

    PubMed  CAS  Google Scholar 

  6. Wiekowski M T, Leach M W, Evans E W et al. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J Immunol, 2001, 166(12):7563

    PubMed  CAS  Google Scholar 

  7. Piskin G, Tursen U, Sylva-Steenland R M et al. Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers — IL-12, IL-18 and IL-23. Exp Dermatol, 2004, 13(12):764

    Article  PubMed  CAS  Google Scholar 

  8. Chamian F, Lowes M A, Lin S L et al. Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc Natl Acad Sci USA, 2005,102(6):2075

    Article  PubMed  CAS  Google Scholar 

  9. Parham C, Chirica M, Timans J et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbetal and a novel cytokine receptor subunit, IL-23R. J Immunol, 2002,168(11):5699

    PubMed  CAS  Google Scholar 

  10. Langrish C L, Chen Y, Blumenschein W M et al. IL-23 drives a pathogenic T cell population that induces auto-immune inflammation. J Exp Med, 2005, 201(2):233

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, X., Tan, Z., Yue, Q. et al. The expression of interleukin-23 (p19/p40) and inteleukin-12 (p35/p40) in psoriasis skin. J. Huazhong Univ. Sc. Technol. 26, 750–752 (2006). https://doi.org/10.1007/s11596-006-0635-z

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-006-0635-z

Key words

Navigation